Product Images Gabapentin

The text describes a trial where pain scores were measured using a numeric scale (from 0 to 10) during a 4-week dose titration period and a subsequent 4-week fixed dose period. The two interventions compared were placebo and gabapentin (3600 mg/day). A baseline measurement was taken as well.*

This appears to be a table with headers for different sections related to a study on pain scores. There are columns labeled with different dose periods and medication types. The text also mentions a baseline and weeks, indicating that pain scores may have been measured over a period of time. However, without more context it is difficult to determine the specifics of the study or what the numbers in the table represent.*

This is a figure showing the proportion of responders in controlled PHN studies. The data in the figure is represented using percentages from 10% to 100%. There are also some numerical values for different studies and treatments, but no further context is provided to understand their meaning. The figure seems to be related to pain reduction, but without more information about the study design, it is difficult to provide a complete interpretation.*

This appears to be a label of a medication. It is being packaged by Bryant Ranck Prepack and is being compared to Neurontin 300mg capsules produced by Alkem Laboratories Limited. The label also provides instructions for storage and a caution to keep the medication out of reach of children. The NDC number is 7133512691 and there is a UPC code of 07306901523487.*